BioAge Labs Ownership | Who Owns BioAge Labs?
BioAge Labs Ownership Summary
BioAge Labs is owned by 22.30% institutional investors, 2.44% insiders, and 75.26% retail investors. Ah capital management is the largest institutional shareholder, holding 9.00% of BIOA shares. Polar Capital Biotech S Inc is the top mutual fund, with 2.41% of its assets in BioAge Labs shares.
BIOA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioAge Labs | 22.30% | 2.44% | 75.26% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ah capital management | 3.23M | 9.00% | $56.55M |
| Cormorant asset management, lp | 2.89M | 8.04% | $50.56M |
| Sofinnova investments | 2.29M | 6.38% | $40.12M |
| Blackrock funding, inc. /de | 2.27M | 6.31% | $39.66M |
| Janus henderson group | 2.09M | 5.83% | $36.60M |
| Adar1 capital management | 1.88M | 5.24% | $11.05M |
| Octagon capital advisors lp | 1.75M | 4.86% | $30.57M |
| Ra capital management | 1.65M | 4.59% | $28.87M |
| Tang capital management | 1.60M | 4.46% | $9.41M |
| Vanguard group | 1.41M | 3.95% | $18.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ah capital management | 3.23M | 4.38% | $56.55M |
| Pivotal bioventure partners investment advisor | 653.37K | 4.08% | $11.43M |
| Octagon capital advisors lp | 1.75M | 3.38% | $30.57M |
| Sands capital ventures | 786.35K | 3.27% | $13.75M |
| Cormorant asset management, lp | 2.89M | 2.54% | $50.56M |
| Sofinnova investments | 2.29M | 1.52% | $40.12M |
| Stempoint capital lp | 338.65K | 1.15% | $5.92M |
| Adar1 capital management | 1.88M | 1.04% | $11.05M |
| Braidwell lp | 1.20M | 0.70% | $21.00M |
| Tang capital management | 1.60M | 0.36% | $9.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 2.09M | 0.02% | 1.69M |
| Ra capital management | 1.65M | 0.31% | 1.65M |
| Balyasny asset management | 1.33M | 0.03% | 1.33M |
| Braidwell lp | 1.20M | 0.70% | 1.20M |
| Polar capital | 1.13M | 0.07% | 1.13M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Suvretta capital management | - | - | -1.45M |
| Rtw investments, lp | - | - | -786.35K |
| Adage capital partners gp | 500.00K | 0.01% | -550.00K |
| Redpoint management | - | - | -383.25K |
| Siren | - | - | -382.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 1.65M | 0.31% | 1.65M | $28.87M |
| Balyasny asset management | 1.33M | 0.03% | 1.33M | $23.22M |
| Braidwell lp | 1.20M | 0.70% | 1.20M | $21.00M |
| Polar capital | 1.13M | 0.07% | 1.13M | $19.81M |
| Stempoint capital lp | 338.65K | 1.15% | 338.65K | $5.92M |
Sold Out
| Holder | Change |
|---|---|
| Srs capital advisors | -4.00 |
| Mendota financial group | -10.00 |
| Clearstead advisors | -18.00 |
| Principal securities | -41.00 |
| Daiwa securities group | -119.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 69 | -39.47% | 8,013,462 | -66.13% | 22 | 0.51% | 42 | -39.13% | 12 | -50.00% |
| Dec 31, 2025 | 65 | -31.58% | 10,078,271 | -52.59% | 28 | 0.80% | 41 | -6.82% | 11 | -47.62% |
| Sep 30, 2025 | 92 | 10.84% | 21,046,072 | 1.59% | 58 | 1.76% | 42 | -23.64% | 20 | 122.22% |
| Jun 30, 2025 | 83 | 27.69% | 20,716,579 | 2.74% | 57 | 1.83% | 55 | 77.42% | 9 | -50.00% |
| Mar 31, 2025 | 65 | 6.56% | 20,244,679 | 3.38% | 56 | 1.37% | 30 | -31.82% | 18 | 80.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Biotech S Inc | 1.07M | 2.41% | - |
| Vanguard Total Stock Mkt Idx Inv | 985.49K | 2.22% | - |
| iShares Russell 2000 ETF | 703.91K | 1.59% | 5.92K |
| Vanguard Institutional Extnd Mkt Idx Tr | 338.24K | 0.76% | 1.80K |
| iShares Russell 2000 Value ETF | 255.14K | 0.57% | 1.37K |
| Fidelity Small Cap Index | 232.56K | 0.52% | 3.09K |
| State Street® SPDR® S&P® PhrmctlsETF | 227.64K | 0.51% | - |
| iShares Biotechnology ETF | 212.90K | 0.48% | 5.94K |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 176.80K | 0.40% | - |
| Fidelity Extended Market Index | 160.64K | 0.36% | 24.63K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $157.08K |
| Mar 02, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $150.89K |
| Feb 02, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $139.37K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell | $239.55K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell | $165.37K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
BIOA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools